RxEconomics LLC is a leading health economics and policy consulting firm that has been providing high-quality services to a diverse clientele since 2011. Our clients include pharmaceutical manufacturers, life sciences companies, employers, health plans, PBMs, trade associations, government entities, and policymakers. With over 25 years of experience conducting observational research studies, we specialize in analyzing patient cost-sharing impacts on prescription drug utilization, and the medical cost savings and productivity enhancements derived from medication adherence. We also provide evaluations of pharmacy benefits, including Value-Based Insurance Designs, and offer legislative analysis and advisory services to clients on healthcare reform. Our team of experts is committed to delivering innovative solutions that address the complex challenges facing the healthcare industry today.
M. Christopher Roebuck is Founder and CEO of RxEconomics LLC. As an applied health economist, he has considerable expertise in employing advanced econometric methods in observational research studies using insurance claims data. Additionally, Dr. Roebuck has significant experience in developing predictive models, conducting economic evaluations of health care programs, and examining issues of health plan choice. His work has been published in American Economic Review, Southern Economic Journal, Health Affairs, Medical Care, American Journal of Managed Care, and Health Services Research. He and his colleagues received the Best Abstract Award at the 2006 Annual Research Meeting of Academy Health, and the Health Care Research Award of the National Institute for Health Care Management Foundation in 2013. He holds a B.A. in Economics from the University of Pennsylvania, an M.B.A. in Finance from the University of Miami, and a Ph.D. in Public Policy from the University of Maryland, Baltimore County.